Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review.

Beni Verma, Ashwin Kumar, Nikita Verma, Ankit Agrawal, Abdullah Yesilyaprak, Muhammad M Furqan, Gauranga Mahalwar, Felix Berglund, Sayan Manna, Mary Schleicher, Pejman Raeisi-Giglou, Mohamed Nasser, Ahmad Jabri, Tom Kai Ming Wang, Allan L Klein

Journal: Heart (British Cardiac Society) 2023;109(17):1281-1285

PMID: 36702544

Abstract

OBJECTIVE

Chylopericardium (CPE) is a rare condition associated with accumulation of triglyceride-rich chylous fluid in the pericardial cavity. Due to minimal information on CPE within the literature, we conducted a systematic review of all published CPE cases to understand its clinical characteristics, management and outcomes.

METHODS

We performed a literature search and identified cases of patients with CPE from 1946 until May 2021 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We identified relevant articles for pooled analyses of clinical, diagnostic and outcome data.

RESULTS

A total of 95 articles with 98 patients were identified. Patient demographics demonstrated male predominance (55%), with a mean age of 37±15 years. Time from symptom onset to diagnosis was 5 (Q1 4.5, Q3 14) days, with 74% of patients symptomatic on presentation. Idiopathic CPE (60%) was the most common aetiology. Cardiac tamponade secondary to CPE was seen in 38% of cases. Pericardial fluid analysis was required in 94% of cases. Lymphangiography identified the leakage site in 59% of patients. Medical therapy (total parenteral nutrition, medium-chain triglycerides or octreotide) was undertaken in 63% of cases. In our cohort, 32% progressed towards surgical intervention. During a median follow-up of 180 (Q1 180, Q3 377) days, CPE recurred in 16% of cases. Of the patients with recurrence, 10% were rehospitalised.

CONCLUSION

CPE tends to develop in younger patients and may cause serious complications. Many patients fail medical therapy, thereby requiring surgical intervention. Although overall mortality is low, associated morbidities warrant close follow-up and possible reintervention and hospitalisations.

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Address: Center for the Diagnosis and Treatment of Pericardial Diseases,Section of Cardiovascular Imaging,Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Department of Cardiovascuar Medicine, MetroHealth Medical Center, Cleveland, Ohio, USA.; Department of Internal Medicine, MedStar Georgetown University Hospital, Washington, District of Columbia, USA.; Department of Medicine, Baba Farid University of Health Sciences, Faridkot, Punjab, India.; Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, USA.; Cleveland Clinic Akron General, Akron, Ohio, USA.; Mallinckrodt Institute Department of Radiology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.; EIectronic Library Services,Research Innovation and Education, Cleveland Clinic, Cleveland, Ohio, USA.; Center for the Diagnosis and Treatment of Pericardial Diseases,Section of Cardiovascular Imaging,Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.